These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30553299)

  • 21. Management of patients with intermediate-thickness melanoma.
    Urist MM
    Annu Rev Med; 1996; 47():211-7. PubMed ID: 8712776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metastasectomy for stage IV melanoma.
    Deutsch GB; Kirchoff DD; Faries MB
    Surg Oncol Clin N Am; 2015 Apr; 24(2):279-98. PubMed ID: 25769712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
    Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA
    Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical treatment of malignant melanoma: practical guidelines.
    Levine SM; Shapiro RL
    Dermatol Clin; 2012 Jul; 30(3):487-501. PubMed ID: 22800553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma.
    Essner R
    Expert Rev Anticancer Ther; 2010 May; 10(5):723-8. PubMed ID: 20470004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classification and staging of melanoma.
    Gershenwald JE; Buzaid AC; Ross MI
    Clin Lab Med; 2000 Dec; 20(4):785-815. PubMed ID: 11221515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Staging investigations and the U.K. guidelines for cutaneous melanoma.
    Shoaib T; Dunn R; Soutar DS
    Br J Dermatol; 2002 Oct; 147(4):837-8; author reply 838. PubMed ID: 12366459
    [No Abstract]   [Full Text] [Related]  

  • 28. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients.
    Gershenwald JE; Thompson W; Mansfield PF; Lee JE; Colome MI; Tseng CH; Lee JJ; Balch CM; Reintgen DS; Ross MI
    J Clin Oncol; 1999 Mar; 17(3):976-83. PubMed ID: 10071292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New developments in sentinel node staging in melanoma: controversies and alternatives.
    van Akkooi AC; Voit CA; Verhoef C; Eggermont AM
    Curr Opin Oncol; 2010 May; 22(3):169-77. PubMed ID: 20168231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biopsy procedures, primary wide excisional surgery and long term prognosis in primary clinical stage I invasive cutaneous malignant melanoma.
    Griffiths RW; Briggs JC
    Ann R Coll Surg Engl; 1985 Mar; 67(2):75-8. PubMed ID: 3977262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel-lymph-node biopsy for cutaneous melanoma.
    Gershenwald JE; Ross MI
    N Engl J Med; 2011 May; 364(18):1738-45. PubMed ID: 21542744
    [No Abstract]   [Full Text] [Related]  

  • 32. Evidence-based management of melanoma. Clinical practice guidelines are now available for managing this cancer which occurs in relatively young people and is a particular problem in Australia.
    McCarthy WH
    Med J Aust; 2000 Sep; 173(6):286-7. PubMed ID: 11061395
    [No Abstract]   [Full Text] [Related]  

  • 33. A retrospective comparison between preoperative and postoperative Breslow depth in primary cutaneous melanoma: how preoperative shave biopsies affect surgical management.
    Saco M; Thigpen J
    J Drugs Dermatol; 2014 May; 13(5):531-6. PubMed ID: 24809875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
    Serban ED; Farnetani F; Pellacani G; Constantin MM
    Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma.
    Turner RM; Bell KJ; Morton RL; Hayen A; Francken AB; Howard K; Armstrong B; Thompson JF; Irwig L
    J Clin Oncol; 2011 Dec; 29(35):4641-6. PubMed ID: 22067399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of initial tumor stage on patient follow-up after potentially curative surgery for cutaneous melanoma.
    Johnson FE; Virgo KS; Johnson DY; Chan D; Goshima K; Handler BS
    Int J Oncol; 2001 May; 18(5):973-8. PubMed ID: 11295043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elective lymph node dissection for melanoma: two perspectives.
    McCarthy WH; Shaw HM; Cascinelli N; Santinami M; Belli F
    World J Surg; 1992; 16(2):203-13. PubMed ID: 1561800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant melanoma of the vulva: an extension of cutaneous melanoma?
    Moxley KM; Fader AN; Rose PG; Case AS; Mutch DG; Berry E; Schink JC; Kim CH; Chi DS; Moore KN
    Gynecol Oncol; 2011 Sep; 122(3):612-7. PubMed ID: 21570710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.